198 related articles for article (PubMed ID: 34089975)
1. Chemical prioritisation strategy in the European Human Biomonitoring Initiative (HBM4EU) - Development and results.
Ougier E; Ganzleben C; Lecoq P; Bessems J; David M; Schoeters G; Lange R; Meslin M; Uhl M; Kolossa-Gehring M; Rousselle C; Vicente JL
Int J Hyg Environ Health; 2021 Jul; 236():113778. PubMed ID: 34089975
[TBL] [Abstract][Full Text] [Related]
2. Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessment.
Apel P; Rousselle C; Lange R; Sissoko F; Kolossa-Gehring M; Ougier E
Int J Hyg Environ Health; 2020 Sep; 230():113622. PubMed ID: 33045523
[TBL] [Abstract][Full Text] [Related]
3. Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population.
Buekers J; David M; Koppen G; Bessems J; Scheringer M; Lebret E; Sarigiannis D; Kolossa-Gehring M; Berglund M; Schoeters G; Trier X
Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30248963
[TBL] [Abstract][Full Text] [Related]
4. Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for bisphenol A.
Ougier E; Zeman F; Antignac JP; Rousselle C; Lange R; Kolossa-Gehring M; Apel P
Environ Int; 2021 Sep; 154():106563. PubMed ID: 33894553
[TBL] [Abstract][Full Text] [Related]
5. The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) for the aprotic solvents N-methyl-2-pyrrolidone (NMP) and N-ethyl-2-pyrrolidone (NEP).
David M; Gerofke A; Lange R; Kolossa-Gehring M; Apel P
Int J Hyg Environ Health; 2021 Sep; 238():113856. PubMed ID: 34619432
[TBL] [Abstract][Full Text] [Related]
6. Phthalates and substitute plasticizers: Main achievements from the European human biomonitoring initiative HBM4EU.
Gerofke A; Lange R; Vogel N; Schmidt P; Weber T; David M; Frederiksen H; Baken K; Govarts E; Gilles L; Martin LR; Martinsone Ž; Santonen T; Schoeters G; Scheringer M; Domínguez-Romero E; López ME; Calvo AC; Koch HM; Apel P; Kolossa-Gehring M
Int J Hyg Environ Health; 2024 Jun; 259():114378. PubMed ID: 38631089
[TBL] [Abstract][Full Text] [Related]
7. Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future.
Louro H; Heinälä M; Bessems J; Buekers J; Vermeire T; Woutersen M; van Engelen J; Borges T; Rousselle C; Ougier E; Alvito P; Martins C; Assunção R; Silva MJ; Pronk A; Schaddelee-Scholten B; Del Carmen Gonzalez M; de Alba M; Castaño A; Viegas S; Humar-Juric T; Kononenko L; Lampen A; Vinggaard AM; Schoeters G; Kolossa-Gehring M; Santonen T
Int J Hyg Environ Health; 2019 Jun; 222(5):727-737. PubMed ID: 31176761
[TBL] [Abstract][Full Text] [Related]
8. The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values for selected phthalates and a substitute plasticizer.
Lange R; Apel P; Rousselle C; Charles S; Sissoko F; Kolossa-Gehring M; Ougier E
Int J Hyg Environ Health; 2021 May; 234():113722. PubMed ID: 33711757
[TBL] [Abstract][Full Text] [Related]
9. HBM4EU combines and harmonises human biomonitoring data across the EU, building on existing capacity - The HBM4EU survey.
Gilles L; Govarts E; Rambaud L; Vogel N; Castaño A; Esteban López M; Rodriguez Martin L; Koppen G; Remy S; Vrijheid M; Montazeri P; Birks L; Sepai O; Stewart L; Fiddicke U; Loots I; Knudsen LE; Kolossa-Gehring M; Schoeters G
Int J Hyg Environ Health; 2021 Aug; 237():113809. PubMed ID: 34455198
[TBL] [Abstract][Full Text] [Related]
10. Harmonised human biomonitoring in Europe: activities towards an EU HBM framework.
Joas R; Casteleyn L; Biot P; Kolossa-Gehring M; Castano A; Angerer J; Schoeters G; Sepai O; Knudsen LE; Joas A; Horvat M; Bloemen L
Int J Hyg Environ Health; 2012 Feb; 215(2):172-5. PubMed ID: 21940209
[TBL] [Abstract][Full Text] [Related]
11. Learning from previous work and finding synergies in the domains of public and environmental health: EU-funded projects BRIDGE Health and HBM4EU.
David M; Schwedler G; Reiber L; Tolonen H; Andersson AM; Esteban López M; Joas A; Schöpel M; Polcher A; Kolossa-Gehring M
Arch Public Health; 2020; 78():78. PubMed ID: 32944237
[TBL] [Abstract][Full Text] [Related]
12. Policy recommendations and cost implications for a more sustainable framework for European human biomonitoring surveys.
Joas A; Knudsen LE; Kolossa-Gehring M; Sepai O; Casteleyn L; Schoeters G; Angerer J; Castaño A; Aerts D; Biot P; Horvat M; Bloemen L; Reis MF; Lupsa IR; Katsonouri A; Cerna M; Berglund M; Crettaz P; Rudnai P; Halzlova K; Mulcahy M; Gutleb AC; Fischer ME; Becher G; Fréry N; Jensen G; Van Vliet L; Koch HM; Den Hond E; Fiddicke U; Esteban M; Exley K; Schwedler G; Seiwert M; Ligocka D; Hohenblum P; Kyrtopoulos S; Botsivali M; DeFelip E; Guillou C; Reniero F; Grazuleviciene R; Veidebaum T; Mørck TA; Nielsen JK; Jensen JF; Rivas TC; Sanchez J; Koppen G; Smolders R; Kozepesy S; Hadjipanayis A; Krskova A; Mannion R; Jakubowski M; Fucic JA; Pereira-Miguel J; Gurzau AE; Jajcaj M; Mazej D; Tratnik JS; Lehmann A; Larsson K; Dumez B; Joas R
Environ Res; 2015 Aug; 141():42-57. PubMed ID: 25526891
[TBL] [Abstract][Full Text] [Related]
13. HBM4EU chromates study - Reflection and lessons learnt from designing and undertaking a collaborative European biomonitoring study on occupational exposure to hexavalent chromium.
Galea KS; Porras SP; Viegas S; Bocca B; Bousoumah R; Duca RC; Godderis L; Iavicoli I; Janasik B; Jones K; Knudsen LE; Leese E; Leso V; Louro H; Ndaw S; Ruggieri F; Sepai O; Scheepers PTJ; Silva MJ; Wasowicz W; Santonen T
Int J Hyg Environ Health; 2021 May; 234():113725. PubMed ID: 33714856
[TBL] [Abstract][Full Text] [Related]
14. Human biomonitoring: state of the art.
Angerer J; Ewers U; Wilhelm M
Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
[TBL] [Abstract][Full Text] [Related]
15. Substitutes mimic the exposure behaviour of REACH regulated phthalates - A review of the German HBM system on the example of plasticizers.
Lemke N; Murawski A; Lange R; Weber T; Apel P; Dębiak M; Koch HM; Kolossa-Gehring M
Int J Hyg Environ Health; 2021 Jul; 236():113780. PubMed ID: 34126298
[TBL] [Abstract][Full Text] [Related]
16. Translating biomonitoring data into risk management and policy implementation options for a European Network on Human Biomonitoring.
Smolders R; Koppen G; Schoeters G
Environ Health; 2008 Jun; 7 Suppl 1(Suppl 1):S2. PubMed ID: 18541068
[TBL] [Abstract][Full Text] [Related]
17. Towards a systematic use of effect biomarkers in population and occupational biomonitoring.
Zare Jeddi M; Hopf NB; Viegas S; Price AB; Paini A; van Thriel C; Benfenati E; Ndaw S; Bessems J; Behnisch PA; Leng G; Duca RC; Verhagen H; Cubadda F; Brennan L; Ali I; David A; Mustieles V; Fernandez MF; Louro H; Pasanen-Kase R
Environ Int; 2021 Jan; 146():106257. PubMed ID: 33395925
[TBL] [Abstract][Full Text] [Related]
18. Setting up a collaborative European human biological monitoring study on occupational exposure to hexavalent chromium.
Santonen T; Alimonti A; Bocca B; Duca RC; Galea KS; Godderis L; Göen T; Gomes B; Hanser O; Iavicoli I; Janasik B; Jones K; Kiilunen M; Koch HM; Leese E; Leso V; Louro H; Ndaw S; Porras SP; Robert A; Ruggieri F; Scheepers PTJ; Silva MJ; Viegas S; Wasowicz W; Castano A; Sepai O
Environ Res; 2019 Oct; 177():108583. PubMed ID: 31330491
[TBL] [Abstract][Full Text] [Related]
19. Environmental Substances Associated with Osteoporosis-A Scoping Review.
Elonheimo H; Lange R; Tolonen H; Kolossa-Gehring M
Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33467108
[TBL] [Abstract][Full Text] [Related]
20. Challenges to Evidence Synthesis and Identification of Data Gaps in Human Biomonitoring.
Virgolino A; Santos O; Costa J; Fialho M; Iavicoli I; Santonen T; Tolonen H; Samoli E; Katsouyanni K; Baltatzis G; Ruggieri F; Abballe A; Petrovičová I; Kolena B; Šidlovská M; Ancona C; Eržen I; Sepai O; Castaño A; Kolossa-Gehring M; Fiddicke U
Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33802154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
